Affinity-Based Detection of Ligand-Encoded Synthetic Biomarkers
Invention type: Technology
/
Case number: #16292H
The invention relates to methods and products associated with in vivo enzyme profiling. In particular, biomarker nanoparticles capable of quantitatively detecting enzymatic activity in vivo are described. These nanoparticles can be used to detect in vivo enzyme activity. The invention also relates to products, kits, and databases for use in the methods of the invention.
Researchers
David Wood
/
Gabriel Kwong
/
Kevin Lin
/
Andrew Warren
/
Sangeeta Bhatia
Departments: Health Sciences and Technology Program
Technology Areas: Biotechnology: Sensors & Monitoring / Diagnostics: Assays
Impact Areas: Healthy Living
-
affinity-based detection of ligand-encoded synthetic biomarkers
United States of America | Granted | 10,527,619 -
affinity-based detection of ligand-encoded synthetic biomarkers
China | Published application -
affinity-based detection of ligand-encoded synthetic biomarkers
Japan | Granted | 6,847,660 -
affinity-based detection of ligand-encoded synthetic biomarkers
European Patent Convention | Granted | 3,004,374 -
affinity-based detection of ligand-encoded synthetic biomarkers
Japan | Granted | 7,017,544 -
affinity-based detection of ligand-encoded synthetic biomarkers
United States of America | Granted | 11,977,074 -
affinity-based detection of ligand-encoded synthetic biomarkers
United Kingdom | Granted | 3,004,374 -
affinity-based detection of ligand-encoded synthetic biomarkers
Japan | Granted | 7,368,868 -
affinity-based detection of ligand-encoded synthetic biomarkers
Japan | Pending -
affinity-based detection of ligand-encoded synthetic biomarkers
China | Published application
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.